Caroline Popper

Caroline Popper MD MPH is an internist and pathologist and is the former CEO of Diversigen, a microbiome-focused pharma-services company, recently acquired by Orasure Technologies.

Dr. Popper has more than 25 years of hands-on life science operating experience. She combines her medical and scientific perspective with knowledge gained from managing a wide spectrum of life sciences businesses in both Fortune 500 and start-up settings in the US and globally. She maintains a large venture and private equity network, sits on several company boards, and speaks internationally on healthcare innovation and value analysis.

Dr. Popper received her medical degree from the University of the Witwatersrand (South Africa) and her M.P.H. from Johns Hopkins University (Baltimore). She completed her residencies in internal medicine and in pathology at Johns Hopkins.